Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP^Ser239) in platelets is increased by nitrite and partially deoxygenated erythrocytes

• Sirada Srihirun,

  Roles Investigation, Writing – original draft

  Affiliations Molecular Medicine Branch, National Institute of Diabetes Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America, Department of Pharmacology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand

  ⨯
• Barbora Piknova,

  Roles Conceptualization, Data curation, Writing – review & editing

  Affiliation Molecular Medicine Branch, National Institute of Diabetes Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Nathawut Sibmooh,

  Roles Conceptualization, Writing – review & editing

  Affiliation Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand

  ⨯
• Alan N. Schechter

  Roles Conceptualization, Data curation, Resources, Supervision, Writing – review & editing

  * E-mail: AlanS@intra.niddk.nih.gov

  Affiliation Molecular Medicine Branch, National Institute of Diabetes Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  http://orcid.org/0000-0002-6055-6452

  ⨯